Clinical Trials

1 clinical trial matches your search

NCT06064877

AV-299-23-301: A Phase 3 Study of Ficlatuzumab in Combination with Cetuximab in Subjects with Recurrent or Metastatic (R/M) HPV-Negative Head and Neck Squamous Cell Carcinoma

This study is currently enrolling.

Associated Conditions: Head & Neck

Research Area: Clinical Cancer Research

Research Location: Orlando

The main purpose of this study is to investigate the safety, effectiveness, and tolerability (whether side effects can be handled by a participant) of ficlatuzumab at two different doses when given...